India  

Three vaccines await FDA approval

Video Credit: FOX 4 Now Florida - Duration: 00:55s - Published
Three vaccines await FDA approval

Three vaccines await FDA approval

Drug maker Astrazeneca announcing today its vaccine candidate was up to 90 percent effective in large-scale trials.

HER WORLD...AND EXPLAINS WHY THEABUSE MAY NOT ALWAYS LOOK THEWAY YOU THINK IT DOES....THERE ARE NOW THREE VACCINESWAITING FOR F-D-A APPROVAL ..DRUG MAKER ASTRAZENECAANNOUNCING TODAY ITS VACCINECANDIDATE WAS UP TO 90 PERCENTEFFECTIVE IN LARGE-SCALE TRIALS.IT’S THE THIRD VACCINE TO REACHTHAT POINT - BUT UNLIKE THE ONESMADE BY COMPETITORS PFIZER ANDMODERNA....ASTRAZENECA’SCANDIDATE DOES NOT NEED TO BESTORED IN SPECIALTY FREEZERS.IT’S ALSO SIGNIFICANTLY LESSEXPENSIVE.

THE NEXT STEP ISREGULATORY APPROVAL - WHICHCOULD COME IN AS LITTLE AS THREEWEEKS."We have to vaccinate seventypercent to bring it up to alevel where it really slows itdown....We will be able toaccomplish this with thesevaccines."F-D-A OFFICIALS WILL BEMEETING ON DECEMBER 10TH TOCONSIDER PFIZER’S REQUEST FOREMERGENCY USE AUTHORIZATION.AS FOR CORONAVIRUS CASES IN OURSTAT




You Might Like


Related videos from verified sources

Moderna's COVID-19 Vaccine - What's Next And Why Masks Will Still Be Needed [Video]

Moderna's COVID-19 Vaccine - What's Next And Why Masks Will Still Be Needed

Dr. Mallika Marshall explains the FDA approval process for vaccines and why masks will still be needed next year.

Credit: WBZ CBS Boston     Duration: 01:42Published
Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval [Video]

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval. Moderna will submit its coronavirus vaccine on Nov. 30. It is the second drugmaker to ask the FDA for emergency use..

Credit: Wibbitz Top Stories     Duration: 01:03Published
Pfizer and BioNTech's COVID-19 Vaccine to Be Submitted for Emergency Authorization [Video]

Pfizer and BioNTech's COVID-19 Vaccine to Be Submitted for Emergency Authorization

Pfizer and BioNTech's, COVID-19 Vaccine to Be , Submitted for Emergency Authorization. The vaccine created by the companies is known as BNT162b2. It is the first coronavirus vaccine to be..

Credit: Wibbitz Top Stories     Duration: 01:02Published